학술논문
Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review.
Document Type
Article
Author
Source
Health Economics Review; 2/16/2024, Vol. 14, p1-37, 37p
Subject
Language
ISSN
21911991
Abstract
Copyright of Health Economics Review is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)